Over the last decades, T-cell immunotherapy has revealed itself as a powerful, and often
curative, strategy to treat blood cancers. In hematopoietic cell transplantation, most of the so …

Lymphoma is a common hematologic malignant tumor that originates from lymph nodes or
other lymphoid tissues. The tumor microenvironment (TME) plays an indispensable role in …

Reconstitution of the T cell repertoire after allogeneic stem cell transplantation is a long and
often incomplete process. As a result, reactivation of Epstein-Barr virus (EBV) is a frequent …

Patients with cancer require efficient treatment approaches as the mortality rate due to their
disease is high. Conventional therapies, like chemotherapy and radiation, have severe side …

Background T-cell lymphoma (TCL) is highly aggressive and has a poor prognosis; thus, it is
worth exploring biomarkers that may predict clinical outcomes and investigate their potential …

T-cell lymphomas represent non-Hodgkin lymphomas distinguished by the uncontrolled
proliferation of malignant T lymphocytes. Classifying these neoplasms and the ongoing …

The synthesis of novel 1, 1′‐disubstituted ferrocene conjugates appended with N‐1 and O‐
4 alkylated quinolone and quinoline was reported. The target compounds were synthesized …

This study aimed to develop comprehensive nomograms for patients with head and neck
non-Hodgkin lymphoma (H&NNHL) to determine their overall survival (OS) and cancer …

T-cell lymphomas (TCLs) have a unique pathobiology, clinically aggressive course, and
poor prognosis. Recently, there have been significant advances in understanding the …

Background: T-cell lymphomas constitute a heterogeneous group of hematological
malignancies with global poor outcomes. Computed tomography (CT)-based texture …